| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/09/2006 | CN1813709A Safflower yellow dropping pill, and its preparing method and use |
| 08/09/2006 | CN1813708A Amiodarone hydro chloride dispensible tablet, and its preparing method |
| 08/09/2006 | CN1813707A Medicinal composition containing isosorbide mononitrate for treating hypertension |
| 08/09/2006 | CN1813706A Use of elastic protease inhibitor for preparing medicine for protecting cerebral hemorrhage |
| 08/09/2006 | CN1813705A Chlorogenic acid injection, its preparing method and use |
| 08/09/2006 | CN1813704A Magnesium chlorogenate medicinal composition, its preparing method and use |
| 08/09/2006 | CN1813703A Acetyglutamide aluminium oral tablet, capsule and its preparing method |
| 08/09/2006 | CN1813702A Ketoprofen cataplasm and its preparing method |
| 08/09/2006 | CN1813701A Medicine, health product and food additive containing rare-earth element non-polysaccharide compound |
| 08/09/2006 | CN1813700A Compound injection composed of probenecid and penicillin antibiotic |
| 08/09/2006 | CN1813699A Medicinal composition |
| 08/09/2006 | CN1813698A Anti-pruritic formulation containing capsaicin, and its preparing method and use |
| 08/09/2006 | CN1813697A Terbinafine hydrochloride vagina gel, and its preparing and quality control method |
| 08/09/2006 | CN1813696A Levalbuterol slow-release tablet and its preparing method |
| 08/09/2006 | CN1813695A Terbutaline sulfate dropping pill and its preparing method |
| 08/09/2006 | CN1813694A Clenbuterol hydrochloride dropping pill and its preparing method |
| 08/09/2006 | CN1813693A Dopexamine hydrochloride injection and its preparing method |
| 08/09/2006 | CN1813692A Irisquinonum injection emulsion and its preparing method |
| 08/09/2006 | CN1813691A Decanoyl acetaldehyde compound and its medicinal composition |
| 08/09/2006 | CN1813690A Asarone injection emulsion and its preparing method |
| 08/09/2006 | CN1813689A Asarone fatty emulsion and its preparing method |
| 08/09/2006 | CN1813687A Method for preparing tinidazole biological composite membrane |
| 08/09/2006 | CN1813686A Montelukast oral disintegrating tablet formulation and its preparing method |
| 08/09/2006 | CN1813685A Couted particle for reinforcing pidotimod acid-base stability, and its production method and use |
| 08/09/2006 | CN1813684A Method for preparing 5-fluorouracil/chitosan nano drug-carrying microsphere |
| 08/09/2006 | CN1813683A Azithromycin for suspension and its preparing method |
| 08/09/2006 | CN1813681A Sodium vitamin C powder for injection and its preparing method |
| 08/09/2006 | CN1813680A Isepamicin sulfate powder for injection and its preparing method |
| 08/09/2006 | CN1813679A Taxane liposome lyophilized composition and its preparing method |
| 08/09/2006 | CN1813677A Quercetin long-acting liposome powder for injection and its preparing method |
| 08/09/2006 | CN1813676A Anthracene ring antitumor medicinal liposome and its production process |
| 08/09/2006 | CN1813675A Galanthamine hydrobromide composition and its preparing method |
| 08/09/2006 | CN1813674A Sodium vitamin C formulation for intravenous administration and its preparing method |
| 08/09/2006 | CN1813673A Isepamicin sulfate formulation for intravenous administration and its preparing method |
| 08/09/2006 | CN1813641A Combined complete product for nursing infant umbilical cord and its use method |
| 08/09/2006 | CN1813559A Composition for regulating animal growth, method of manufacture and use thereof |
| 08/09/2006 | CN1268753C Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/09/2006 | CN1268743C genetic construct for coding cell targeting part and heterologous precursor activating enzyme, and its application |
| 08/09/2006 | CN1268650C Process for preparing low moledule heparin calcium of low nitrite content |
| 08/09/2006 | CN1268640C Glucagon-like peptide-2 analogs |
| 08/09/2006 | CN1268637C I (chlamydia) protein, gene sequence and uses thereof |
| 08/09/2006 | CN1268632C Method for preparing a glucosamine compound, and compound thus obtained |
| 08/09/2006 | CN1268630C Synthesis for compound of diamine bridge linking ortho phenanthroline hydrous lanthanum (III) and anti-cancer activity thereof |
| 08/09/2006 | CN1268626C Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268624C A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidine-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride |
| 08/09/2006 | CN1268623C Novel composition and method or stabilizing same |
| 08/09/2006 | CN1268620C Preparing process and medicine composition of andrographolide derivatives |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/09/2006 | CN1268614C Substituted pyrazolyl benzsulfamide compound for curing inflammation |
| 08/09/2006 | CN1268610C Sulfonamide derivatives |
| 08/09/2006 | CN1268600C Method for the nitration of phenolic compounds |
| 08/09/2006 | CN1268396C Compositions of estrogen-cyclodextrin complexes |
| 08/09/2006 | CN1268395C Remedies for chronic kidney diseases |
| 08/09/2006 | CN1268357C Medicine composition for treating furuncle, abscess, carbuncle, furuncle, burn and scald |
| 08/09/2006 | CN1268355C Traditional Chinese medicine for treating cow endo metritis |
| 08/09/2006 | CN1268351C Sugar absorption inhibitors and process for producing the same |
| 08/09/2006 | CN1268346C Biological polysaccharide micro-capsule, preparing. method and application thereof |
| 08/09/2006 | CN1268345C Method of treating hepatitis delta viral infection |
| 08/09/2006 | CN1268344C Puerarin gelation for eye use and preparing. method |
| 08/09/2006 | CN1268343C Compositions of asiatic centella and Hypericum perforatum extracts and its antidepressant action |
| 08/09/2006 | CN1268342C 药物组合物 The pharmaceutical composition of |
| 08/09/2006 | CN1268341C Tubiflorous desert cistanche preparing containing phenethyl alcohol glycoside and its preparing process and use |
| 08/09/2006 | CN1268340C Pharmaceutical composition comprising condensed indole compound |
| 08/09/2006 | CN1268339C Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia |
| 08/09/2006 | CN1268338C Oral administration of 6-hydroxy-oxymorphone for use as antalgesic |
| 08/09/2006 | CN1268337C Desloratadine dry-mixed suspensoid and preparing method thereof |
| 08/09/2006 | CN1268336C Pharmaceutical composition, dosage form, and method of epothilones for oral administration |
| 08/09/2006 | CN1268335C Nucleoside analogs with carboxamidine wodified monocyclic base |
| 08/09/2006 | CN1268334C Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 08/09/2006 | CN1268333C Indolinone compounds for the treatment of disease |
| 08/09/2006 | CN1268332C Kappa opiate agonists for treatment of bladder diseases |
| 08/09/2006 | CN1268331C Use of inhibitors of renin-angiotensin systemin prevention of cardiovascular events |
| 08/09/2006 | CN1268330C Process for producing medicine grade natural vitamin E raw oil |
| 08/09/2006 | CN1268329C Use of substances that act as cascade inhibitors of the Raf/MEK/ERK signal cascade, for producing a medicament to treat DNA and RNA viruses |
| 08/09/2006 | CN1268328C Coenzyme q and eicosapentaenoic acid (EPA) |
| 08/09/2006 | CN1268327C Brufen arginine pseudoephedrine hydrochloride compound formulation |
| 08/09/2006 | CN1268326C Novel formulations of alpha 2,4-disulforphenyl-N-tert-butylnitrone |
| 08/09/2006 | CN1268323C Rhodiola sacra soft capsule and its preparation |
| 08/09/2006 | CN1268322C Pharmaceutical compositions comprising amlodipine maleate |
| 08/09/2006 | CN1268319C Rhodiola sacra injection and its preparation |
| 08/09/2006 | CN1268234C Method and compositions for increasing anaerobic working capacity in tissues |
| 08/09/2006 | CA2602083A1 Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods |
| 08/08/2006 | WO2006059237A1 4-phenylbutyric acid controlled-release formulations for therapeutic use |
| 08/08/2006 | US7087790 Benzotropolone derivatives and modulation of inflammatory response |
| 08/08/2006 | US7087786 phenylpyrazole compounds or 5-amino-1-aryl-3-cyanopyrazole; high yield and high purity; eliminates the diazotization step and hence avoids hazards known to occur for such reactions |
| 08/08/2006 | US7087785 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide |
| 08/08/2006 | US7087776 Silanol enzyme inhibitors |
| 08/08/2006 | US7087765 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087758 Quinoline inhibitors of hyaki and hyak3 kinases |
| 08/08/2006 | US7087757 Phenyl-substituted imidazopyridines |
| 08/08/2006 | US7087756 6-(4-Dimethylaminomethyl-phenyl)-3-phenyl-5H-isoxazolo[4,5-c]pyridine-4-one and 6-[4-(2-Methoxy-ethoxymethyl)-phenyl]-5-methyl-3-phenyl-5H-isoxazolo[4,5-c]pyridin-4-one; use treating Parkinson's disease |
| 08/08/2006 | US7087755 2-substituted pyridine-4-boronic acids created by reacting a metallated pyridine with an electrophile; useful in combinatorial approaches by virtue of their boronic moiety and at least one additional functional group |
| 08/08/2006 | US7087754 Parkinson's disease; antidepressants; cognition activators; analgesics; brain disorders |
| 08/08/2006 | US7087751 Diazotizing 5-amino-1H-imidazole-4-carboxamide derivative having divalent protecting group on amide that is readily removable by hydrolysis or hydrogenolysis |
| 08/08/2006 | US7087750 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 08/08/2006 | US7087749 Substituted piperidine compounds and methods of their use |
| 08/08/2006 | US7087745 Biocompatible and biodegradable, obtained by precipitation induced by supercritical antisolvent (SAS); used in the field of medicine and surgery |
| 08/08/2006 | US7087743 Bleaching; skin disorders; genetic engineered nucleic acid; topical applying |